FIELD: pharmaceutics.
SUBSTANCE: invention relates to agent with nootropic and anti-autistic activity, representing tetrazole-containing derivative of 4-amino-3-phenyl-butyric acid of general formula (I):
in which X=O, N, R2=H, CH3, X=O, R1=methyl, ethyl, H, X=N, R1=2-(pyridin-4-yl)ethyl, isopropyl. Invention also relates to pharmaceutical composition, medicinal agent and method of improving training processes, memory, cognitive functions.
EFFECT: technical result: obtaining agent effective in treating disorders of cognitive functions, as well as for symptomatic therapy at autistic disorders.
4 cl, 3 dwg, 16 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATING AND PREVENTING DISORDERS OF AUTISM SPECTRUM | 2015 |
|
RU2608444C1 |
AGENT FOR CORRECTING AUTISM SPECTRUM DISORDERS | 2017 |
|
RU2666598C1 |
ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
PEPTIDE HAVING NEUROPROTECTIVE AND NOOTROPIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2014 |
|
RU2557003C2 |
ADAMANTYL DERIVATIVES OF BENZIMIDAZOLE, HAVING ANTIPARKINSONIAN ACTIVITY | 2023 |
|
RU2820315C1 |
MEDICATION FOR TREATING AND PREVENTION OF ALCOHOLISM | 2014 |
|
RU2574001C1 |
USE OF RASAGILINE FOR TREATMENT OF OLFACTORY DYSFUNCTION | 2011 |
|
RU2587330C2 |
PHARMACEUTICAL COMPOSITION BASED ON N-BENZYL-N-METHYL-1-PHENYLPYRROLO [1,2-A] PYRAZINE-3-CARBOXAMIDE | 2017 |
|
RU2689396C2 |
3-(2-(4-FLUOROPHENYL)-2-OXOETHYLIDENE)-3,4-DIHYDRO-2H-BENZO[b][1,4]OXAZIN-2-ON BASED SEDATIVE | 2021 |
|
RU2788047C1 |
EMPLOYMENT OF FLUORINATED TRIAZOLES FOR SUPPRESSING PAIN AND AFFECT DYSFUNCTIONS AND DISORDER OF ATTENTION | 2000 |
|
RU2238725C2 |
Authors
Dates
2017-03-13—Published
2015-10-05—Filed